MyAverix Finance
HK · Healthcare
VIVA Biotech Holdings (1873)
Biotechnology
VIVA Biotech Holdings (1873) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $2.96B, P/E ratio is 20.14, net margin is 12.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1873
VIVA Biotech Holdings (1873) — FAQ
What is VIVA Biotech Holdings's market cap?
VIVA Biotech Holdings (1873) has a reported market cap of $2.96B (data as of 2026-05-21).
What is 1873's P/E ratio?
The price-to-earnings (P/E) ratio for VIVA Biotech Holdings (1873) is 20.14 (data as of 2026-05-21).
Does VIVA Biotech Holdings pay a dividend?
Dividend yield is not available in the current snapshot for VIVA Biotech Holdings (1873). Check the MyAverix Finance app for the latest dividend data.
What sector is VIVA Biotech Holdings in?
VIVA Biotech Holdings (1873) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1873 listed on?
1873 is listed on HK.
What is VIVA Biotech Holdings's net margin?
VIVA Biotech Holdings (1873) reports a net margin of 12.7% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.